Let's Combinate - Pharma + Medical Devices with Subhi Saadeh
Let's Combinate - Pharma + Medical Devices with Subhi Saadeh
Subhi Saadeh
117 - Post Market Surveillance, Safety Reporting, Databases, Platforms Health Hazards Assessments and Product Responsibilities with Khaudeja Bano
34 minutes Posted Jan 3, 2024 at 11:00 am.
Post-Market Safety Reporting
Challenges in Post-Market Safety Reporting
Reporting Databases
21 CFR Part 4b Guidance
Managing Product Responsibilities
Challenges in Handling Platforms
Understanding Health Hazard Assessment
International Approach to Reporting
0:00
34:33
Download MP3
Show notes
On this episode, I was joined by Khaudeja Bano, VP of Quality for Combination Products at Amgen.
In this episode, the we discuss the details related to post-market safety reporting for combination products. The conversation extends to the comparison connecting safety and quality, the importance of cross-functional teams for risk management, and the approach towards health hazard assessments. Additionally, they delve into managing product responsibilities, the varied international reporting requirements, and the use of technology for improved efficiency.
Dr. Khaudeja Bano is the VP of Combination Products Quality at Amgen. Executive director of combination product safety. She's held multiple roles at other companies as well like Abbvie, Abbott, and Guidant and is the chair of the Post Market Safety committee for the combination products coalition.